Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

NCT04893525 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

658

Enrollment

OTHER

Sponsor class

Conditions

Opioid-use Disorder

Interventions

DRUG: Buprenorphine/naloxone

Sponsor

University of British Columbia